Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
1 other identifier
observational
50
0 countries
N/A
Brief Summary
The investigators are finding out if giving antibiotics for Helicobacter pylori will eliminate colonization of the colon by Oxalobacter formigenes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2003
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 18, 2011
CompletedFirst Posted
Study publicly available on registry
February 21, 2011
CompletedFebruary 21, 2011
February 1, 2011
5.4 years
February 18, 2011
February 18, 2011
Conditions
Keywords
Study Arms (2)
Antibiotics for H. pylori
Patients who underwent upper endoscopy and were found to have H. pylori, and were then to be treated with antibiotics for eradication of H. pylori
Control group, no H. pylori
Patients who underwent upper endoscopy and found to not have H. pylori, and then would not receive antibiotics
Eligibility Criteria
Patients undergoing upper endoscopy for any indication and who would have determination of presence or absence of H. pylori. Stool samples then positive for colonization with Oxalobacter formigenes.
You may qualify if:
- age 18-80 years old
- undergoing upper endoscopy
- H. pylori present or absent on gastric histology
- stool positive for Oxalobacter formigenes
You may not qualify if:
- unable to consent
- stool negative for Oxalobacter formigenes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David S Goldfarb, MD
New York Harbor VA Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
Study Record Dates
First Submitted
February 18, 2011
First Posted
February 21, 2011
Study Start
January 1, 2003
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
February 21, 2011
Record last verified: 2011-02